Literature DB >> 20418893

Comparable rate of EGFR kinase domain mutation in lung adenocarcinomas from Chinese male and female never-smokers.

Yi-hua Sun, Rong Fang, Bin Gao, Xiang-kun Han, Jun-hua Zhang, William Pao, Hai-quan Chen, Hong-bin Ji.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20418893      PMCID： PMC3990499          DOI： 10.1038/aps.2010.43

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN： 1671-4083            Impact factor:   6.150


× No keyword cloud information.
  11 in total

1.  Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications.

Authors:  Takayuki Kosaka; Yasushi Yatabe; Hideki Endoh; Hiroyuki Kuwano; Takashi Takahashi; Tetsuya Mitsudomi
Journal:  Cancer Res       Date:  2004-12-15       Impact factor: 12.701

2.  [EGFR gene mutation status among lung cancer patients in China].

Authors:  Qi Li; Ya-li Zhao; Hao-jie Hao; Xiang-hong Li
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2007-04

3.  Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers.

Authors:  Hisayuki Shigematsu; Li Lin; Takao Takahashi; Masaharu Nomura; Makoto Suzuki; Ignacio I Wistuba; Kwun M Fong; Huei Lee; Shinichi Toyooka; Nobuyoshi Shimizu; Takehiko Fujisawa; Ziding Feng; Jack A Roth; Joachim Herz; John D Minna; Adi F Gazdar
Journal:  J Natl Cancer Inst       Date:  2005-03-02       Impact factor: 13.506

4.  Frequency of and variables associated with the EGFR mutation and its subtypes.

Authors:  Tomoaki Tanaka; Masaru Matsuoka; Akihisa Sutani; Akihiko Gemma; Makoto Maemondo; Akira Inoue; Shoji Okinaga; Makoto Nagashima; Satoshi Oizumi; Kazutsugu Uematsu; Yoshiaki Nagai; Gaku Moriyama; Hitoshi Miyazawa; Kenji Ikebuchi; Satoshi Morita; Kunihiko Kobayashi; Koichi Hagiwara
Journal:  Int J Cancer       Date:  2010-02-01       Impact factor: 7.396

5.  EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib.

Authors:  William Pao; Vincent Miller; Maureen Zakowski; Jennifer Doherty; Katerina Politi; Inderpal Sarkaria; Bhuvanesh Singh; Robert Heelan; Valerie Rusch; Lucinda Fulton; Elaine Mardis; Doris Kupfer; Richard Wilson; Mark Kris; Harold Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-25       Impact factor: 11.205

Review 6.  Biomarkers of response to epidermal growth factor receptor inhibitors in Non-Small-Cell Lung Cancer Working Group: standardization for use in the clinical trial setting.

Authors:  David A Eberhard; Giuseppe Giaccone; Bruce E Johnson
Journal:  J Clin Oncol       Date:  2008-02-20       Impact factor: 44.544

7.  EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Authors:  J Guillermo Paez; Pasi A Jänne; Jeffrey C Lee; Sean Tracy; Heidi Greulich; Stacey Gabriel; Paula Herman; Frederic J Kaye; Neal Lindeman; Titus J Boggon; Katsuhiko Naoki; Hidefumi Sasaki; Yoshitaka Fujii; Michael J Eck; William R Sellers; Bruce E Johnson; Matthew Meyerson
Journal:  Science       Date:  2004-04-29       Impact factor: 47.728

8.  Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.

Authors:  Thomas J Lynch; Daphne W Bell; Raffaella Sordella; Sarada Gurubhagavatula; Ross A Okimoto; Brian W Brannigan; Patricia L Harris; Sara M Haserlat; Jeffrey G Supko; Frank G Haluska; David N Louis; David C Christiani; Jeff Settleman; Daniel A Haber
Journal:  N Engl J Med       Date:  2004-04-29       Impact factor: 91.245

Review 9.  EGFR tyrosine kinase inhibitors for the treatment of NSCLC in East Asia: present and future.

Authors:  Chih-Hsin Yang
Journal:  Lung Cancer       Date:  2008-06       Impact factor: 5.705

10.  Epidermal growth factor receptor mutations in plasma DNA samples predict tumor response in Chinese patients with stages IIIB to IV non-small-cell lung cancer.

Authors:  Hua Bai; Li Mao; Hang Shu Wang; Jun Zhao; Lu Yang; Tong Tong An; Xin Wang; Chun Jian Duan; Na Mei Wu; Zhi Qing Guo; Yi Xu Liu; Hong Ning Liu; Ye Yu Wang; Jie Wang
Journal:  J Clin Oncol       Date:  2009-05-04       Impact factor: 44.544
View more
  7 in total

1.  Establishment and characterization of primary lung cancer cell lines from Chinese population.

Authors:  Chao Zheng; Yi-hua Sun; Xiao-lei Ye; Hai-quan Chen; Hong-bin Ji
Journal:  Acta Pharmacol Sin       Date:  2011-03       Impact factor: 6.150

2.  Distribution of EGFR Mutations in 10,607 Russian Patients with Lung Cancer.

Authors:  Evgeny N Imyanitov; Irina A Demidova; Marat G Gordiev; Maxim L Filipenko; Tatyana V Kekeyeva; Yuri K Moliaka; Polina A Gervas; Valeriy B Kozhemyako; Dmitriy I Vodolazhskiy; Liubov A Sergeyeva; Dinara U Fattakhova; Aglaya G Iyevleva; Natalia V Mitiushkina; Ekatherina Sh Kuligina; Alexey A Barinov; Meriiam S Mommaeva; Svetlana N Aleksakhina; Ilya V Tsimafeyeu; Sergey A Tjulandin
Journal:  Mol Diagn Ther       Date:  2016-08       Impact factor: 4.074

3.  Spectrum of oncogenic driver mutations in lung adenocarcinomas from East Asian never smokers.

Authors:  Chenguang Li; Rong Fang; Yihua Sun; Xiangkun Han; Fei Li; Bin Gao; A John Iafrate; Xin-Yuan Liu; William Pao; Haiquan Chen; Hongbin Ji
Journal:  PLoS One       Date:  2011-11-30       Impact factor: 3.240

4.  The mutation rates of EGFR in non-small cell lung cancer and KRAS in colorectal cancer of Chinese patients as detected by pyrosequencing using a novel dispensation order.

Authors:  Guohua Xie; Fang Xie; Ping Wu; Xiangliang Yuan; Yanhui Ma; Yunchuan Xu; Li Li; Ling Xu; Ming Yang; Lisong Shen
Journal:  J Exp Clin Cancer Res       Date:  2015-06-18

5.  Frequency of EGFR mutations in 907 lung adenocarcioma patients of Indian ethnicity.

Authors:  Anuradha Chougule; Kumar Prabhash; Vanita Noronha; Amit Joshi; Abhishek Thavamani; Pratik Chandrani; Pawan Upadhyay; Sagarika Utture; Saral Desai; Nirmala Jambhekar; Amit Dutt
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

6.  Concurrent radiotherapy with gefitinib in elderly patients with esophageal squamous cell carcinoma: Preliminary results of a phase II study.

Authors:  Yaping Xu; Yuanda Zheng; Xiaojiang Sun; Xinmin Yu; Jialei Gu; Wei Wu; Gu Zhang; Jinlin Hu; Wenyong Sun; Weimin Mao
Journal:  Oncotarget       Date:  2015-11-10

7.  Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology - Mainland China Subset Analysis of the PIONEER study.

Authors:  Yuankai Shi; Junling Li; Shucai Zhang; Mengzhao Wang; Shujun Yang; Ning Li; Gang Wu; Wei Liu; Guoqing Liao; Kaican Cai; Liang'an Chen; Meizhen Zheng; Ping Yu; Xiuwen Wang; Yunpeng Liu; Qisen Guo; Ligong Nie; Jiwei Liu; Xiaohong Han
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.